- Home
- PED vs VERU Comparison
PED vs VERU Comparison
Compare PED & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- VERU
- Stock Information
- Founded
- PED N/A
- VERU 1971
- Country
- PED United States
- VERU United States
- Employees
- PED N/A
- VERU N/A
- Industry
- PED Oil & Gas Production
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- VERU Health Care
- Exchange
- PED Nasdaq
- VERU Nasdaq
- Market Cap
- PED 49.1M
- VERU 40.6M
- IPO Year
- PED N/A
- VERU 1990
- Fundamental
- Price
- PED $0.48
- VERU $2.29
- Analyst Decision
- PED Strong Buy
- VERU Strong Buy
- Analyst Count
- PED 1
- VERU 2
- Target Price
- PED $1.50
- VERU $25.00
- AVG Volume (30 Days)
- PED 164.5K
- VERU 197.4K
- Earning Date
- PED 11-17-2025
- VERU 12-15-2025
- Dividend Yield
- PED N/A
- VERU N/A
- EPS Growth
- PED 156.43
- VERU N/A
- EPS
- PED 0.11
- VERU N/A
- Revenue
- PED $33,244,999.00
- VERU $16,886,419.00
- Revenue This Year
- PED N/A
- VERU N/A
- Revenue Next Year
- PED $17.41
- VERU N/A
- P/E Ratio
- PED $4.40
- VERU N/A
- Revenue Growth
- PED N/A
- VERU 337.24
- 52 Week Low
- PED $0.45
- VERU $2.11
- 52 Week High
- PED $1.00
- VERU $14.20
- Technical
- Relative Strength Index (RSI)
- PED 29.29
- VERU 34.16
- Support Level
- PED $0.45
- VERU $2.11
- Resistance Level
- PED $0.54
- VERU $2.57
- Average True Range (ATR)
- PED 0.03
- VERU 0.19
- MACD
- PED -0.01
- VERU -0.00
- Stochastic Oscillator
- PED 12.21
- VERU 35.33
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.